CCM
GOSS icon

Cinctive Capital Management’s Gossamer Bio GOSS Stock Holding History

Cinctive Capital Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-103,519
Closed -$866K – 521
2022
Q2 		$866K Buy
+103,519
New +$802K 0.04% 413

Other funds holding GOSS

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

Cinctive Capital Management's GOSS Position: Q3 2022 in Review

Cinctive Capital Management sold out of Gossamer Bio (GOSS) in Q3 2022, closing a stake of 103,519 shares — an estimated $866K sold.

Cinctive Capital Management first reported a position in GOSS in Q2 2022 and held it in 1 quarter. The position peaked at $866K in Q2 2022. 160 funds tracked by Wall St. Rank hold GOSS as of Q3 2022.

  • Cinctive Capital Management reported no remaining Gossamer Bio position as of Q3 2022 after selling out during the quarter.
  • Cinctive Capital Management sold 103,519 Gossamer Bio shares in Q3 2022, an estimated $866K.
  • Cinctive Capital Management first reported a position in Gossamer Bio in Q2 2022 and held it in 1 quarter.
  • Cinctive Capital Management's Gossamer Bio position peaked at $866K in Q2 2022.
  • 160 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2022.

Based on Cinctive Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.